Interestingly, Jia and colleagues proposed in their functional experiment studies in AML patients that TIGIT expression might be correlated with increased secretion of IFN-γ and TNF-α cytokines and granzyme B, supporting the NK anti-tumor activity in AML [105]. This evidence concerns the gene TIGIT and acute myeloid leukemia.